Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MHY1485 是一种 mTOR 激活剂。它通过抑制自噬体和溶酶体之间的融合来抑制自噬过程,导致 LC3II 蛋白的积累和自噬体增大。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 153 | 现货 | ||
5 mg | ¥ 328 | 现货 | ||
10 mg | ¥ 578 | 现货 | ||
25 mg | ¥ 1,120 | 现货 | ||
50 mg | ¥ 1,870 | 现货 | ||
100 mg | ¥ 3,320 | 现货 | ||
200 mg | ¥ 4,820 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 397 | 现货 |
产品描述 | MHY1485 is a mTOR activator. It inhibits the autophagic process by inhibition of fusion between autophagosomes and lysosomes, leading to the accumulation of LC3II protein and enlarged autophagosomes. |
体内活性 | MHY1485增加磷酸化mTOR水平和下游S6K1和rpS6蛋白的磷酸化,而不影响总mTOR含量,总S6K1和rpS6水平。卵巢经MHY1485短期处理后进行异种移植,可促进次级毛囊生长。MHY1485处理后进行移植,可促进成熟卵母细胞的生成,并产生健康后代。MHY1485以剂量和时间依赖性方式引起LC3II的聚集和自噬体的扩大。 |
激酶实验 | Ovaries from mice at day10 of age are treated with 10 μM MHY1485 for 3h and proteins are extracted using M-PER Mammalian Protein Extraction Reagent containing a protease inhibitor cocktail. Protein concentrations in supernatants are determined by the bicinchoninic acid method. Equal amounts of protein lysates are loaded on 4-12% NuPAGE Bis-Tris gels in MOPS buffer and transferred to 0.45 μM pore nitrocellulose membranes[2]. |
细胞实验 | MHY1485 is dissolved in DMSO and then diluted with appropriate media[3]. MC3T3-E1 cells are maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in a humidified atmosphere of 5% CO2. Having reached 70% confluence, the culture medium is switched to commercial osteogenic differentiation medium. MC3T3-E1 cells are cultured in the osteogenic differentiation medium for 14 days, following by culture in DMEM supplemented with varying concentrations of liraglutide (catalog no. HY-P0014; MedChem Express) for a further 14 days. MC3T3-E1 cells treated with 4 nM liraglutide are cultured in the presence or absence of Compound C or MHY1485. MC3T3-E1 cells maintained in DMEM for 28 days in the absence of any treatment are used as the negative control (NC); cells cultured in commercial osteogenic differentiation medium for 14 days and in DMEM without liraglutide for an additional 14 days are used as the positive control (PC)[3]. |
分子量 | 387.39 |
分子式 | C17H21N7O4 |
CAS No. | 326914-06-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 9 mg/mL(23.2 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5814 mL | 12.9069 mL | 25.8138 mL | 64.5344 mL |
5 mM | 0.5163 mL | 2.5814 mL | 5.1628 mL | 12.9069 mL | |
10 mM | 0.2581 mL | 1.2907 mL | 2.5814 mL | 6.4534 mL | |
20 mM | 0.1291 mL | 0.6453 mL | 1.2907 mL | 3.2267 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MHY1485 326914-06-1 Autophagy PI3K/Akt/mTOR signaling mTOR cell MC3T3-E1 FSH MHY 1485 Inhibitor cell-permeable Mammalian target of Rapamycin inhibit MHY-1485 inhibitor